NCT07328711

Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B

RecruitingEARLY_PHASE1INTERVENTIONAL

Trial Details

Start: 2026-01-01Est. Completion: 2028-12-31

Enrollment target: 132 participants

Locations

Contact

Chronic Hepaititis B

This is an open-label study with single- and multiple-ascending dose arms followed by a dose expansion arm. The primary …

Lyon, FranceEst. completion Dec 31, 2032

Chronic Hepaititis B Infections

This Phase 1 non-randomized, open-label, single-dose hepatic impairment study consists of 2 cohorts, conducted in 16 sub…

Orlando, United StatesEst. completion Apr 20, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.